P15121 ALDR_HUMAN
Gene name: AKR1B1
Protein name: Aldo-keto reductase family 1 member B1
List of molecules and drugs that target protein P15121
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P15121_DB00143 | DB00143 | Glutathione | n/a | RWSXRVCMGQZWBV-WDSKDSINSA-N | N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O | |
2 | P15121_DB00157 | DB00157 | NADH | n/a | BOPGDPNILDQYTO-NNYOXOHSSA-N | NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O | |
3 | P15121_DB00605 | DB00605 | Sulindac | inhibitor | MLKXDPUZXIRXEP-MFOYZWKCSA-N | CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O | |
4 | P15121_DB01689 | DB01689 | Inhibitor Idd 384 | n/a | IC50(nM) = 108.0 | CJKKMQCZOLCXAM-UHFFFAOYSA-N | CC1=CC=CC=C1CC(=O)NC1=CC(C)=C(C(C)=C1)S(=O)(=O)NCC(O)=O |
5 | P15121_DB02007 | DB02007 | alpha-D-glucose 6-phosphate | n/a | NBSCHQHZLSJFNQ-DVKNGEFBSA-N | O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O | |
6 | P15121_DB02020 | DB02020 | Alrestatin | n/a | Ki(nM) = 2000.0 IC50(nM) = 6500.0 | GCUCIFQCGJIRNT-UHFFFAOYSA-N | OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23 |
7 | P15121_DB02021 | DB02021 | Fidarestat | inhibitor | WAAPEIZFCHNLKK-UFBFGSQYSA-N | NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)C2=C(O1)C=CC(F)=C2 | |
8 | P15121_DB02101 | DB02101 | (S,R)-fidarestat | n/a | IC50(nM) = 570.0 | WAAPEIZFCHNLKK-QPUJVOFHSA-N | [H]N([H])C(=O)[C@@H]1C[C@@]2(N([H])C(=O)N([H])C2=O)C2=C(O1)C=CC(F)=C2 |
9 | P15121_DB02132 | DB02132 | Zenarestat | n/a | IC50(nM) = 8.0 | SXONDGSPUVNZLO-UHFFFAOYSA-N | OC(=O)CN1C(=O)N(CC2=C(F)C=C(Br)C=C2)C(=O)C2=C1C=C(Cl)C=C2 |
10 | P15121_DB02383 | DB02383 | Tolrestat | inhibitor | IC50(nM) = 1.0 | LUBHDINQXIHVLS-UHFFFAOYSA-N | COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F |
11 | P15121_DB02518 | DB02518 | N-Acetylalanine | n/a | KTHDTJVBEPMMGL-VKHMYHEASA-N | C[C@H](NC(C)=O)C(O)=O | |
12 | P15121_DB02712 | DB02712 | Sorbinil | inhibitor | IC50(nM) = 67.0 | LXANPKRCLVQAOG-NSHDSACASA-N | FC1=CC=C2OCC[C@]3(NC(=O)NC3=O)C2=C1 |
13 | P15121_DB02834 | DB02834 | IDD552 | n/a | IC50(nM) = 11.0 | ZCAGEXZTORJQDZ-UHFFFAOYSA-N | OC(=O)COC1=CC(F)=CC=C1C(=O)NCC1=NC2=C(S1)C(F)=CC(F)=C2F |
14 | P15121_DB02994 | DB02994 | Cacodylic acid | n/a | OGGXGZAMXPVRFZ-UHFFFAOYSA-N | C[As](C)(O)=O | |
15 | P15121_DB03461 | DB03461 | Nicotinamide adenine dinucleotide phosphate | n/a | XJLXINKUBYWONI-NNYOXOHSSA-N | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O | |
16 | P15121_DB04272 | DB04272 | Citric acid | inhibitor | KRKNYBCHXYNGOX-UHFFFAOYSA-N | OC(=O)CC(O)(CC(O)=O)C(O)=O | |
17 | P15121_DB05327 | DB05327 | Ranirestat | n/a | IC50(nM) = 15.0 | QCVNMNYRNIMDKV-QGZVFWFLSA-N | FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1 |
18 | P15121_DB05383 | DB05383 | Pimagedine | n/a | HAMNKKUPIHEESI-UHFFFAOYSA-N | NNC(N)=N | |
19 | P15121_DB06246 | DB06246 | Exisulind | inhibitor | MVGSNCBCUWPVDA-MFOYZWKCSA-N | CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O | |
20 | P15121_DB07028 | DB07028 | (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID | n/a | IC50(nM) = 30.0 | ZLIGBZRXAQNUFO-UHFFFAOYSA-N | OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=C(F)C=C(Br)C=C1 |
21 | P15121_DB07030 | DB07030 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | n/a | IC50(nM) = 6.0 Kd(nM) = 14.0 | VABIMMIJVWNHFI-UHFFFAOYSA-N | OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=CC(=CC=C1)[N+]([O-])=O |
22 | P15121_DB07063 | DB07063 | Lidorestat | n/a | IC50(nM) = 5.0 | KYHVTMFADJNSGS-UHFFFAOYSA-N | OC(=O)CN1C=C(CC2=NC3=C(F)C(F)=CC(F)=C3S2)C2=C1C=CC=C2 |
23 | P15121_DB07093 | DB07093 | {3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID | n/a | RQWICELTTDJODO-UHFFFAOYSA-N | OC(=O)CN1C=CC(=O)N(CC2=NC3=CC(Cl)=CC=C3S2)C1=O | |
24 | P15121_DB07139 | DB07139 | 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid | n/a | IHKCOKRMJRDWAL-UHFFFAOYSA-N | OC(=O)CCC1=CC=C(S1)C1=CC(=CC=C1)[N+]([O-])=O | |
25 | P15121_DB07187 | DB07187 | CP-744809 | n/a | IC50(nM) = 0.84 | FXFPQPNUMWQRAO-UHFFFAOYSA-N | CC1=C(OC2=CC=C(Cl)C=C12)S(=O)(=O)C1=NNC(=O)C=C1 |
26 | P15121_DB07450 | DB07450 | (R)-minalrestat | n/a | IC50(nM) = 12.2 | BMHZAHGTGIZZCT-LJQANCHMSA-N | [H]N1C(=O)C[C@@]2(C1=O)C(=O)N(CC1=C(F)C=C(Br)C=C1)C(=O)C1=C2C=C(F)C=C1 |
27 | P15121_DB07498 | DB07498 | 4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID | n/a | LQQYZJRCWBRIMW-UHFFFAOYSA-N | OC(=O)CCCC1=NC(=NO1)C1=CC(=CC=C1)[N+]([O-])=O | |
28 | P15121_DB07999 | DB07999 | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | n/a | IC50(nM) = 550.0 | IXLBOIRSEDMRPI-UHFFFAOYSA-N | OC(=O)COC(=O)C1=C2C(C(=O)N(CC(O)=O)S2(=O)=O)=C2C=CC=CC2=C1 |
29 | P15121_DB08000 | DB08000 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | n/a | IC50(nM) = 140.0 | ZTJGXDGAXGWOGR-UHFFFAOYSA-N | OC(=O)CN1C(=O)C2=C(C(=CC3=CC=CC=C23)C(O)=O)S1(=O)=O |
30 | P15121_DB08084 | DB08084 | IDD594 | n/a | IC50(nM) = 3.0 | JCZUIWYXULSXSW-UHFFFAOYSA-N | OC(=O)COC1=CC(F)=CC=C1C(=S)NCC1=CC=C(Br)C=C1F |
31 | P15121_DB08098 | DB08098 | {[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid | n/a | IC50(nM) = 4100.0 | ITBNJCVIFHSKRL-UHFFFAOYSA-N | OC(=O)CSC1=NN=C(O1)C1=CC=C(O1)[N+]([O-])=O |
32 | P15121_DB08449 | DB08449 | 2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid | n/a | IC50(nM) = 100000.0 | IEVFQDJUDLCOQY-UHFFFAOYSA-N | OC(=O)CN1C=C(CC2=NC3=C(S2)C(F)=CC(F)=C3F)C2=CC=CN=C12 |
33 | P15121_DB08772 | DB08772 | Zopolrestat | n/a | Ki(nM) = 19.0 IC50(nM) = 1.9 | BCSVCWVQNOXFGL-UHFFFAOYSA-N | OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1C=CC=C2 |
34 | P15121_DB16707 | DB16707 | Gavorestat | inhibitor | ORQGHAJIWGGFJK-UHFFFAOYSA-N | OC(=O)CC1=NN(CC2=NC3=CC(=CC=C3S2)C(F)(F)F)C(=O)C2=CSC=C12 |